564
Participants
Start Date
February 28, 2024
Primary Completion Date
February 28, 2025
Study Completion Date
February 28, 2025
Itopride Hydrochloride 150 mg extended release tablets
"The intervention in the study is in form of test and active control groups- see details below • Test group - Itopride Hydrochloride 150 mg extended release tablets once daily before one of the main meals (preferably the same meal throughout the treatment)~• Active Control group - Itopride Hydrochloride 50 mg film coated tablets 3 times daily before meals"
Itopride Hydrochloride 50 mg film coated tablets
"The intervention in the study is in form of test and active control groups- see details below • Test group - Itopride Hydrochloride 150 mg extended release tablets once daily before one of the main meals (preferably the same meal throughout the treatment)~• Active Control group - Itopride Hydrochloride 50 mg film coated tablets 3 times daily before meals"
GreenCity Medical Center, Pampanga
Cebu Doctors University Hospital, Cebu City
Davao Doctors Hospital, Davao City
Phramongkulklao Hospital, Bangkok
King Chulalongkorn Memorial, Bangkok
Srinagarind Hospital, Khon Kaen
Maharaj Nakorn Chiang Mai Hospital, Chiang Mai
Nguyen Tri Phuong Hospital, Ho Chi Minh City
"Grigor Narekatsi MC, CJSC", Yerevan
"Hera Med LLC (Medicus Medical Center)", Yerevan
"Institute of Surgery Mickaelyan CJSC", Yerevan
Polyclinic N 12 Health State, CJSC, Yerevan
Hospital Sultanah Bahiyah, Alor Star
Queen Elizabeth Hospital, Kota Kinabalu
Pantai Hospital Kuala Lumpur, Kuala Lumpur
UMMC, Petaling Jaya
Health Cube Medical Clinics, Manila
103 Military Hospital, Hanoi
Bach Mai Hospital, Hanoi
Lead Sponsor
Abbott
INDUSTRY